Concord Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. The exact nature of the certificate is not specified in the headline, but such filings typically relate to compliance with dematerialization of shares, reconciliation of share capital, or other depositary-related obligations. No financial figures, dividends, or corporate actions are mentioned in this update. This appears to be a routine regulatory compliance submission by the company.
This is a routine regulatory compliance filing with no direct impact on shareholders, business operations, or stock price. Investors should note it purely as a standard SEBI requirement being fulfilled by the company.